Biotech Startups

Elephas develops elive, a live-tissue platform technology that predicts immunotherapy response in cancer patients by measuring real-time immune activity in intact tumor tissue. The company serves oncologists and patients to enable personalized cancer treatment selection.

1 investor

Elgan Pharma is a clinical-stage biopharmaceutical company developing therapies for premature infants and neonates, including treatments for intestinal maturation and retinopathy of prematurity.

1 investor

Elicio Therapeutics is a biopharmaceutical company focused on developing therapeutic treatments.

1 investor

1 investor

ELIGARD is a GnRH agonist medication in injectable form used to treat prostate cancer by reducing testosterone production. The product offers multiple dosing schedules for patients with metastatic castration-sensitive prostate cancer.

1 investor

EligoChem is a drug discovery company staffed by directors with expertise in medicinal and computational chemistry, biology assay development, and screening.

1 investor

Elle, MD is a female-founded biotechnology company developing Livv, a once-monthly, non-hormonal contraceptive ring that works locally in the reproductive tract to prevent fertilization. It aims to expand the device to include emergency contraception, creating a patient-controlled dual-indication contraceptive for women's reproductive health.

1 investor

Ellipses Pharma develops cancer treatments targeting unmet clinical needs across various cancer types and molecular mechanisms.

1 investor

Ellis Bio develops genomic and epigenetic analysis technologies for research and diagnostics, leveraging proprietary RNA and DNA methylation research. The company serves biotech and pharmaceutical organizations seeking advanced sequencing and detection capabilities.

1 investor

Elm Biosciences is a clinical skincare company that develops dermatologist-formulated anti-aging products built around its patent-pending A3O antioxidant complex, sold directly to consumers. Its line includes topical treatments and daily supplements aimed at reducing visible signs of skin aging.

1 investor

Elm Street Ventures is a seed and early-stage venture capital fund that invests in startups with a Yale University connection, typically commercializing research licensed from Yale, as well as companies in the greater New Haven area. Its portfolio spans therapeutics, industrial tools and materials, and climate-focused interventions.

1 investor

A contract manufacturer of probiotic products in various formulations including capsules, suspensions, and syrups for the Indian market since 2018.

1 investor

Elo develops plant-based food ingredients and technologies to enhance nutritional value, taste, and climate resilience in everyday foods. The company works on solutions ranging from novel sweeteners to crop preservation to address food sustainability challenges.

1 investor

Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing small molecule therapeutics designed to address nonsense mutation genetic disorders. The company is advancing exaluren for rare kidney diseases including Alport syndrome and ADPKD through clinical trials.

1 investor

Elphogene develops oncoMonitor, a liquid biopsy molecular test that detects circulating tumor DNA (ctDNA) from patients' blood for non-invasive monitoring of cancer progression and treatment, primarily for colorectal cancer patients. The company is a biotechnology spin-off from the Genomac Research Institute.

1 investor

1 investor

Elutia develops a proprietary drug-eluting biomaterial platform that combines biologic matrices with extended antibiotic release for use in device implantation and soft tissue reconstruction. Its allograft products serve surgeons performing reconstructive and cardiovascular repair procedures in the medical device and regenerative medicine field.

1 investor

Developing EMB-001, a medication treating addiction by targeting the stress activity and response system in the patient's body.

1 investor

Embion Tech develops PREMBION, a feed additive derived from hydrolyzed brewer's spent grains designed to improve animal gut performance and reduce antibiotic use in livestock farming. The product targets broiler poultry producers seeking antibiotic-free farming solutions while upcycling an agricultural byproduct.

1 investor

Emblok develops the Emblok 360° whole body embolic protection system, a medical device used during left heart procedures such as TAVR to block and capture emboli and debris. It aims to reduce the risk of procedure-related strokes and damage to the heart, kidneys, and intestines for physicians and patients.

1 investor

Developer of biointegrative soft tissue regeneration solutions for orthopedic injuries; acquired by Zimmer Biomet in 2023.

1 investor

Emerald Inno develops a contactless health monitoring device that uses radio wave analysis and machine learning to detect human movement and extract clinical health data without wearables or manual data synchronization. The platform serves clinical research and health studies with proprietary algorithms that process behavioral and movement data.

1 investor

Emerald BioAgriculture develops biology-based products and solutions using advanced biomanufacturing processes for plant, animal, and human health across various markets. The company specializes in biochemistry, microbials, enzymes, amino acids, peptides, and nutrients with integrated capabilities from discovery through manufacturing.

1 investor

eMolecules operates a digital chemical search platform and procurement service connecting researchers to over 83 million available chemical compounds from a global supplier network. The company serves drug discovery researchers and biopharmaceutical organizations seeking to reduce timelines and improve efficiencies in early-stage compound acquisition and management.

1 investor